Latest HPV Stories
Xpert HPV is the Only Test Capable of Reporting High-risk Human Papillomavirus DNA in Captured Cervical Cells SUNNYVALE, Calif., April 2, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD)
RnRMarketResearch.com adds Latest Report on “Cervical Cancer Test Market & Patients – Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide” to its store.
Preventive services like HPV vaccination and colorectal cancer screening are important tools in reducing cancer rates ATLANTA, March 27, 2014 /PRNewswire-USNewswire/ -- Rates of invasive cancer
The Foundation for Women’s Cancer applauds the decision made by an expert panel at the FDA yesterday to include HPV testing as part of first-line primary screening for cervical cancer.
PLEASANTON, Calif., March 12, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S.
KOLKATA, India, February 26, 2014 /PRNewswire/ -- - The careHPV(TM) Test is the first HPV diagnostic designed for regions with limited healthcare
ST. PAUL, Minn., Feb.
Report Outlines Recommendations to Overcome Barriers and Support Cancer Prevention Efforts WASHINGTON, Feb.
Self-testing for Human Papillomavirus (HPV) – the virus that causes cervical cancer – is as effective at detecting cancer as a conventional smear test (cytology screening) even when scaled up to test large populations.
The risk of developing cervical cancer can be significantly decreased through human papillomavirus (HPV) vaccination.
A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.